FDA NDC Directory · JSON-LD · Markdown

Topiramate

NDC 27241-300 · HUMAN PRESCRIPTION DRUG · CAPSULE, EXTENDED RELEASE

Labeler / ManufacturerAjanta Pharma USA Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA219564
Dosage form / routeCAPSULE, EXTENDED RELEASE · ORAL
Active ingredientsTOPIRAMATE (200 mg/1)
Marketing started20250902
Package count1

External sources

Source: openFDA. Public-domain (CC0).